The clinical laboratory community is examining the potential for patient harm due to another race-based variable: maternal serum screening (MSS) biomarkers. The College of American Pathologists (CAP) requires accredited clinical laboratories to calculate separate MSS biomarker medians for Black and White pregnant patients.
For the full article click here: Championing the Removal of Race-Specific Medians in Maternal Serum Screening